Quarterly results round-up: J&J margins “weak”; Synthes boosted by international performance
This article was originally published in Clinica
Executive Summary
Johnson & Johnson’s devices division has again benefited from positive currency impact during its third fiscal quarter, as it saw sales rise 6% year-on-year to $6.3bn. However, only a third of this increase was due to operational growth; the rest came from favourable exchange rates.